Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study
Samy Hadjadj(Université de Poitiers), M. Fraty(Centre Hospitalier Universitaire de Poitiers), Grégory Ducrocq, Stéphanie Ragot(Université de Tours), Barnabas Gellen(Centre Hospitalier Universitaire Henri-Mondor), Elise Gand(Université de Poitiers), Kamel Mohammedi(Hôpital Cardiologique du Haut-Lévêque), Frédéric Fumeron(Inserm), Gilberto Velho(Inserm), M. Rehman(Communauté urbaine de Lyon), Ronan Roussel(Lyon 1 Université), David Montaigne(Centre Hospitalier Universitaire de Lille), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), P. Sosner(Inserm), Pierre‐Jean Saulnier(Inserm), Michel Marre(Centre National de la Recherche Scientifique)
Cited by 22
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k
PPAR control of metabolism and cardiovascular functions
|Nature Reviews Cardiology|2021|901
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
|New England Journal of Medicine|2014|624